Why is the U.S. government investigating GlaxoSmithKline now?

GlaxoSmithKline recently said U.S. enforcement agencies asked for information about third-party advisers the company hired in China during a corruption investigation in the country. The Man From FCPA asks, why now?

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.